Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.980 | 0 | 0 | 1985 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 2002 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.600 | None | 0.949 | 0 | 0 | 2005 | 2019 | ||||||||
|
solute carrier family 22 member 18 | 0.595 | 0.692 | 6.5E-06 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1998 | 1998 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.985 | 0 | 0 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.942 | 0 | 0 | 1989 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.500 | None | 0.972 | 0 | 0 | 2002 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.500 | None | 0.846 | 0 | 0 | 2000 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.400 | None | 0.979 | 0 | 0 | 1985 | 2019 | ||||||||
|
RPTOR independent companion of MTOR complex 2 | 0.592 | 0.615 | 1.00 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2015 | 2017 | ||||||||
|
RAD21 cohesin complex component | 0.528 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
Ras like without CAAX 1 | 0.527 | 0.808 | 0.13 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
disease | 0.300 | None | 0 | 0 |